Clifford Swan Investment Counsel LLC Bristol Myers Squibb CO Transaction History
Clifford Swan Investment Counsel LLC
- $2.61 Billion
- Q1 2025
A detailed history of Clifford Swan Investment Counsel LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 400,795 shares of BMY stock, worth $18.8 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
400,795
Previous 427,038
6.15%
Holding current value
$18.8 Million
Previous $24.2 Million
1.2%
% of portfolio
0.94%
Previous 0.91%
Shares
32 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.97 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.06 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.44 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.11 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...